Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-03-25

Clinical Trial Update: Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy and safety of combining quetiapine (Seroquel) with a mood stabilizer for maintenance treatment in Bipolar I Disorde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mood stabilizer (unspecified)
  • SEROQUEL (QUETIAPINE)

Snippet

Sponsor: AstraZeneca | Conditions: Bipolar I Disorder | Phase 3 | Status: COMPLETED